Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
9,600
+859
+10% +$185K 0.02% 819
2026
Q1
$1.9M Buy
8,741
+449
+5% +$99.6K 0.03% 674
2025
Q4
$1.89M Sell
8,292
-14,896
-64% -$3.39M 0.02% 707
2025
Q3
$5.37M Sell
23,188
-61,601
-73% -$12.5M 0.06% 383
2025
Q2
$15.7M Buy
+84,789
New +$15.8M 0.17% 137
2024
Q4
Sell
-38,119
Closed -$7.53M 1582
2024
Q3
$7.53M Buy
38,119
+1,125
+3% +$210K 0.15% 140
2024
Q2
$6.35M Buy
36,994
+19,985
+117% +$3.31M 0.13% 176
2024
Q1
$3.1M Buy
17,009
+10,839
+176% +$1.87M 0.08% 277
2023
Q4
$956K Sell
6,170
-43,122
-87% -$6.29M 0.03% 745
2023
Q3
$7.35M Sell
49,292
-7,470
-13% -$1.1M 0.27% 57
2023
Q2
$7.65M Buy
+56,762
New +$8.32M 0.28% 52
2023
Q1
Sell
-2,253
Closed -$364K 1515
2022
Q4
$364K Sell
2,253
-1,867
-45% -$286K 0.02% 922
2022
Q3
$553K Buy
+4,120
New +$591K 0.02% 854
2021
Q4
Sell
-19,923
Closed -$2.15M 1338
2021
Q3
$2.15M Buy
19,923
+17,119
+611% +$1.96M 0.16% 130
2021
Q2
$316K Sell
2,804
-4,436
-61% -$500K 0.03% 652
2021
Q1
$783K Buy
7,240
+3,428
+90% +$367K 0.07% 287
2020
Q4
$408K Buy
+3,812
New +$366K 0.07% 457

Other funds holding ABBV

Jump Financial's ABBV Position: Q2 2026 in Review

Jump Financial increased its AbbVie (ABBV) stake by 9.8% in Q2 2026, buying an estimated $185K and bringing the position to 9,600 shares worth $2.42M. The position accounts for 0.02% of the portfolio, ranked #819.

Jump Financial first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $15.7M in Q2 2025. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jump Financial held 9,600 shares of AbbVie worth $2.42M as of Q2 2026.
  • Jump Financial bought 859 AbbVie shares in Q2 2026, an estimated $185K.
  • AbbVie made up 0.02% of Jump Financial's portfolio in Q2 2026, its #819 holding.
  • Jump Financial first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
  • Jump Financial's AbbVie position peaked at $15.7M in Q2 2025.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.